Invention Grant
- Patent Title: Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
- Patent Title (中): 含有双胍和噻唑烷二酮衍生物的药物制剂
-
Application No.: US13889441Application Date: 2013-05-08
-
Publication No.: US08668931B2Publication Date: 2014-03-11
- Inventor: Unchalee Kositprapa , Robert I. Goldfarb , John R. Cardinal , Avinash Nangia
- Applicant: Watson Pharmaceuticals, Inc.
- Applicant Address: US NJ Parsippany
- Assignee: Actavis, Inc.
- Current Assignee: Actavis, Inc.
- Current Assignee Address: US NJ Parsippany
- Agency: Florek & Endres PLLC
- Main IPC: A61K9/24
- IPC: A61K9/24 ; A61K9/14 ; A61K31/425 ; A61K31/155
Abstract:
A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
Public/Granted literature
- US20130266647A1 NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE Public/Granted day:2013-10-10
Information query
